Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isophane Protamine Recombinant Human Insulin vs Novolin N in Type 2 Diabetes
CTR20210529Phase 3Completed
- Sponsor
- Huisheng Biopharmaceutical
- Start
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of isophane insulin human in type 2 diabetes mellitus (T2DM), sponsored by Huisheng Biopharmaceutical. Started Mar 2021; status: completed.
02
Drugs
isophane insulin human
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20210529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210529.